ホーム>>Signaling Pathways>> Others>> Transcription Factors>>2-(1,8-Naphthyridin-2-yl)phenol

2-(1,8-Naphthyridin-2-yl)phenol (Synonyms: 2-NP)

カタログ番号GC46503

2-(1,8-ナフチリジン-2-イル)フェノールは、STAT1 転写の選択的エンハンサーです。 2-(1,8-ナフチリジン-2-イル)フェノールは、IFN-γの能力を高めることができます。ヒト乳癌および線維肉腫細胞の増殖を阻害します。

Products are for research use only. Not for human use. We do not sell to patients.

2-(1,8-Naphthyridin-2-yl)phenol 化学構造

Cas No.: 65182-56-1

サイズ 価格 在庫数 個数
10mM (in 1mL DMSO)
$71.00
在庫あり
5mg
$65.00
在庫あり
10mg
$111.00
在庫あり
25mg
$222.00
在庫あり
50mg
$352.00
在庫あり
100mg
$565.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

 2-(1,8-Naphthyridin-2-yl)phenol (2-NP) is an enhancer of STAT1 activity.1 It enhances IFN-γ-induced STAT1-dependent signaling, but not IFN-γ-induced STAT3-dependent signaling or TNF-α-induced NF-κB-dependent signaling in cell-based reporter assays when used at a concentration of 45 µM. 2-NP (45 µM) increases IFN-γ-induced expression of the STAT1 target gene IRF3 and STAT1 phosphorylation in NIH3T3 cells. It increases growth inhibition of MCF-7 and 2fTGH cancer cells induced by IFN-γ at the same concentration.

1.Lynch, R.A., Etchin, J., Battle, T.E., et al.A small-molecule enhancer of signal transducer and activator of transcription 1 transcriptional activity accentuates the antiproliferative effects of IFN-γ in human cancer cellsCancer Res.67(3)1254-1261(2007)

レビュー

Review for 2-(1,8-Naphthyridin-2-yl)phenol

Average Rating: 5 ★★★★★ (Based on Reviews and 8 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 2-(1,8-Naphthyridin-2-yl)phenol

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.